Oct4 is a maternally expressed octamer-binding protein encoded by the murine Oct4 gene. It is present in unfertilized oocytes, but also in the inner cell mass and in primordial germ cells. Here we show that the ectopic expression of Oct-4 in HeLa cells is sufficient for transcriptional activation from the octamer motif, indicating that Oct4 is a transcription factor. Therefore, Oct4 is the first transcription factor described that is specific for the early stages of mouse development. The spatial and temporal expression patterns were further determined using in situ hybidization. With this technique Oct4 expression is detected in the oocyte, in the blastocyst and before gastrulation in the embryonic ectoderm. After day 8 Oct4 expression decreases and is restricted to primordial germ cells from about day 8.5 onwards. Therefore Oct4 is a transcription factor that is specifically expressed in cells participating in the generation of the germline lineage. Linkage analysis using B x D recombinant inbred mouse strains demonstrates that Oct4 maps to chromosome 17 in or near the major histocompatibility complex. Several mouse mutants in the distal region of the mouse t-complex affecting blastocyst and embryonic ectoderm formation also map to this region.
Key words: embryogenesis/germline/maternal/octamer/ t-complex Muller-Immergluck et Tanaka et al., 1988; Thali et al., 1988) . In F9 cells the octamer mediates both transcriptional activation (Scholer et al., 1989b) and repression (Lenardo et al., 1989) . In these cells, three octamer-binding proteins are found in addition to the ubiquitously expressed Oct-I protein (Scholer et al., 1989a) . are encoded by the Oct-4 gene (Scholer et al., 1990) whereas the gene encoding Oct-6 remains to be isolated. Oct4 and Oct-5 are also found in primordial germ cells, unfertilized oocytes and in the inner cell mass (ICM) of blastocysts. Therefore, Oct-4 and Oct-5 could control events in early mouse embryogenesis.
We show that expression of Oct-4 cDNA was sufficient to activate transcription from the octamer motif, indicating that Oct-4 is a transcription factor. Also, the expression pattern of the Oct-4 gene during embryogenesis was determined by in situ hybridization and the electrophoretic mobility shift assay (EMSA). In preimplantation embryos, Oct-4 expression was found in the blastocyst and before gastrulation in the embryonic (primitive) ectoderm. Between day 8 and 8.5 p.c., expression decreased dramatically and was restricted at day 8.5 to the primordial germ cells which were identified at the base of the allantois by histological alkaline phosphatase staining (Stinnakre et al., 1981) . The primordial germ cells migrate from the base of the allantois to the genital ridges (Chiquoine, 1954; Clark and Eddy, 1975) where they were easily detected both by their alkaline phosphatase activity and their Oct-4 expression. Linkage analysis using B x D recombinant inbred mouse strains demonstrated that Oct-4 maps in or near the major histocompatibility complex (MHC). A cluster of t-lethal genes are also associated with the MHC (Artzt, 1984) , some of which have profound effects on early mouse development. Correlations between the Oct-4 expression pattern and the phenotype of certain t-haplotypes lethals are discussed.
Introduction
Based on studies with Drosophila, current models of development predict a hierarchy of regulatory genes guiding the transformation of genetic information into embryonic structure (for a review see Ingham, 1988) . A number of mouse genes identified by sequence similarity to Drosophila genes may be involved in pattern formation (Holland and Hogan, 1988; Kessel and Gruss, 1990) . However, these genes are expressed at later stages of mouse development. Identification of regulatory proteins specific for early stages of embryogenesis might help to unravel the predicted developmental gene hierarchy of the mouse.
The octamer motif is a well-characterized cis-acting element found in many promoters and enhancers (for a review see Hatzopoulos et al., 1988) . Octamer-binding proteins from B or HeLa cells regulate transcription via the octamer sequence motif (Dreyfus et al., 1987; Scheidereit et al., 1987; Wirth et al., 1987; LeBowitz et al., 1988;  Oxford University Press Results Transcriptional activation by cloned Oct-4 Depending on its context relative to other motifs, the octamer sequence confers transcriptional activation (Scholer et al., 1989b) or repression (Lenardo et al., 1989) (Scholer et al., 1989a ).
These include Oct-4 and Oct-5, which are differential translation products of the same gene (Figure la; Scholer et al., 1990) .
The Oct-4 cDNA was inserted in both orientations into the eukaryotic CMV expression vector (Severne et al., 1988) used previously to investigate transcriptional activation by Oct-2A (Muller-Immergliick et al., 1988; Schreiber et al., 1988; Thali et al., 1988 Two sets of target vectors were used in the trans-activation experiments. First a set of target vectors was tested that shows that the octamer motif is active in stem cells which contain Oct-4 and Oct-5 (Scholer et al., 1989b Ephrussi et al., 1985) . In F9 stem cells the 6W enhancer is at least 1000-fold more active than the mutated counterpart (Scholer et al., 1989b) . The cDNA-containing expression vectors and the CAT reporter plasmids were co-transfected in different combinations into HeLa cells. Expression of Oct4 and Oct-2A was confirmed by EMSA (data not shown). Reporter gene expression was measured by the CAT assay and compared with expression of a reference gene (,B-actin -lacZ) ( Figure  2) . Surprisingly, trans-activation was not observed with the Oct4 (lanes 6 and 7) or Oct-2A (lanes 1 and 2) expression vectors. Although the CAT activities of p6WtkCAT and pFdtkCAT are higher than ptkCAT (lanes 5 and 10), no difference was observed between 6W and 6Fd, indicating that no trans-activation was occurring via the octamer motif. Activation above ptkCAT control is likely to be due to the 14E4 motif, because similar results were obtained after transfection without trans-activator (Scholer et al., 1989b) .
A second set of target vectors (Figure ld ), in which a single IgH octamer (pD3CAT) or its mutated counterpart (pd,BCAT) is close to the rabbit j3-globin TATA box, was tested in trans-activation assays. This particular arrangement of TATA box and octamer motif is trans-activated by Oct-2A (Scholer et al., 1989a) , blastocysts ( Figure 3 ) and in two cell lines derived from the mouse ICM, D3 (Scholer et al., 1989a) and tI1Il (not shown) (Winking and Guenet, 1978 ). An Oct-4-like protein is also found in the human embryonal carcinoma line NT2 (not shown), a subclone of the Tera-2 cell line (Fogh, 1978) . With the standard procedure (see Materials and methods) this complex has a slightly lower mobility than the F9 Oct-4 complex (not shown). The presence of Oct4 correlates with transcriptional activity via the octamer motif in cells derived from the ICM (Scholer et al., 1989b) . In blastocysts, lacZ expression mediated by the octamer is only in the ICM (Scholer et al., 1989b) .
The distribution of Oct-4 transcripts in the ovary and during early mouse embryogenesis was determined by in situ hybridization using 35S-labelled probes. Sense and antisense RNA probes were transcribed from linearized plasmids containing a 462 bp Oct-4 cDNA insert ( Figure la; fragment C).
To investigate Oct-4 transcription at the preimplantation stage, blastocysts were recovered from the oviduct and uterus, transferred into oviducts and treated as described by ptkCAT) were cotransfected with ,B-actin-lacZ into HeLa cells as indicated. The expression vectors and reporter plasmids are outlined in Figure 1 . Lyons et al. (1989) and Graham et al. (1989) . With this procedure, high levels of Oct-4 transcripts were detectable in the blastocyst ( Oct-4 expression is also found in oocytes, where it is readily detectable in a bright-field image of the ovary ( Figure  3f ). The signal intensity in the blastocyst is much higher than in the oocyte, probably due to higher expression of Oct-4 in the blastocyst (Figure 3g ).
Expression of the Oct-4 gene in the postimplantation embryo At the egg cylinder stage, Oct 4 transcripts can be easily detected in the embryonic ectoderm. Figure 4a , b shows a mid-frontal section through a 7 day embryo where the ectodermal and endodermal germ layers can be easily discerned. High levels of Oct-4 transcripts are visible in the ectoderm, but no transcripts above background are detectable in endoderm, trophoblast, allantois and other extraembryonic tissues. At this stage, mesoderm is formed by ingression through the primitive streak. In a rear-frontal section of a 7 day embryo ( Figure 4c ) and a cross section through a 7.5 day embryo (Figure 4d ), it is apparent that mesoderm does not express Oct-4 at the high levels found in ectoderm. Ectodermal expression can already be detected by day 6 in embryonic ectoderm (data not shown).
By day 8.0 ingression through the primitive streak is almost complete and the neural tube begins to take shape. Oct-4 continues to be expressed in neural ectoderm at high levels, as shown in Figure Sa, (Chiquoine, 1954; Clark and Eddy, 1975) , also express high levels of Oct-4. Figure 6a shows a section of a day 8.5 embryo and Figure 6b an enlarged section. Silver, 1985) . The Oct-4 locus separated from both the a A-crystallin gene (Crya-J) and Ms15-3 in one strain of the B x D RI set; Oct-4 therefore maps between Crya-J and MsJ5-3 (Table I; Vincek et al., 1989) . The estimated map distance of Ms15-3 and H-2 is 1.1 cM and thus Ms15-3 has been placed between H-2 and Tla (Jeffreys et al., 1987; Lyon and Searle, 1989) . This would mean that Oct-4 is within the MHC.
However, as the markers Dl7Leh89 and D17Leh525 also show no recombination with Oct-4 in the B x D series and have been reported to map distally to Tia (Bucan et al., 1987) , it cannot be excluded that Oct-4 and MslS-3 map distally to the MHC complex (Silver, 1985) .
The identical strain distribution patterns for the Oct-4 locus and for sequences in the Tla and H2-S region indicate that Oct-4 maps at least near to the MHC complex. As a first attempt to see if Oct-4 is within the MHC, we examined whether Oct-4 sequences could be detected in any of the cosmids that span large parts of the H2-S, H2-D, H2-Qa and H2-Tla regions (Steinmetz et al., 1982 (Steinmetz et al., , 1984 Fischer et al., 1985; Stephen et al., 1986; Muller et al., 1987) . However, using the Oct-4 cDNA clone as a probe (fragment A in Figure la) , no positive signal was obtained.
Discussion
Oct-4 acts as a transcription factor Oct-4 expression in HeLa cells was driven by the human CMV enhancer, which is very strong in these cells. Transactivation by Oct-4 was studied with two sets of target vectors and the results were compared with those obtained with the Oct-2A transcription factor. The 6W enhancer, a potent enhancer in F9 cells, was not activated by or Oct-2A in HeLa cells. However, a weak promoter consisting only of an octamer next to the TATA box was readily activated in HeLa cells. Several explanations might account for this discrepancy. First, the distances between the TATA boxes and the octamer are different. In the case of p6WtkCAT, the distance is 147 bp, whereas in pD3CAT both motifs are separated by only 20 bp. In p6WtkCAT, two GC boxes and one CAAT box are located between the octamer and the TATA box (Figure 9 ). However, the influence of the GC and CAAT boxes on transcriptional activation in p6WtkCAT remains to be determined. A distance effect between the octamer and TATA box has been described for B-cells (Wirth et al., 1987) . When the octamer motif is within 40 bp upstream of the [B-globin TATA, it is sufficient for directing lymphocyte-specific RNA synthesis. However, moving the octamer -220 bp upstream of the TATA box did not induce transcription. Even with the ectopic expression of Oct-4 or Oct-2A, the octamer motif might act as a proximal promoter element in HeLa cells. Similar results were also obtained by other groups Tanaka and Herr, 1990) . In their experiments co-transfected Oct-2A was only able to act on a nearby TATA and not from a position far upstream or downstream. In BJA-B cells, which contain abundant Oct-2A, even the downstream position was suitable for the stimulation of transcription (Gerster et al., 1987) .
One explanation for the activity of 6W in F9 cells is that cDNA cloning of an octamer-binding protein (Oct-3) from a P19 library. We think that the Oct-3 protein is also encoded by the Oct-4 gene because the nucleotide sequences of the Oct-4 and Oct-3 cDNAs are identical except for two differences (Scholer et al., 1990) . The identity of Oct-4 and Oct-3 is also indicated by Southern blot analysis with restriction-digested mouse DNA (data not shown).
In the functional analysis of the Oct-3 protein, Okamoto et al. (1990) used a target vector that had six tandem repeats of the octamer in front of the SV40 early promoter. Although this vector is active in P19 cells, trans-activation by in differentiated cells could not be demonstrated. This is similar to the results discussed above. To demonstrate that the Oct-3 cDNA encodes a transcription factor they used an indirect approach. When Oct-3 anti-sense RNA was expressed in P19 cells, the activity of the target decreased significantly, indicating that Oct-3 takes part in transcriptional activation.
Oct-4 is a transcrption factor specifically expressed in the germline The regulation of Oct-4 expression during early embryogenesis is a dynamic, multi-step process (Figure 8 ). Both male and female primordial germ cells express Oct-4 as determined by EMSA (Scholer et al., 1989a) and in situ hybridization to mRNA. However, unfertilized oocytes contain Oct-4 protein whereas sperm does not. Upon fertilization, maternal Oct4 would be the only Oct4 source in the zygote until zygotic gene transcription is activated. The stage at which Oct-4 is first transcribed in the zygote is unclear. However, Oct-4 is actively transcribed in the preimplantation embryo and expression increases and continues only in the ICM during blastocyst development. Interestingly, the 6W enhancer is active in ICM and not in the trophectoderm of transgenic blastocysts (Scholer et al., 1989b) . The activity of the octamer in the ICM matches with its activity in the embryonal stem cell line D3, itself derived from the ICM of blastocysts. Moreover, the D3 cell line contains protein, as does the embryonal carcinoma cell line F9. In both cases the activity of the octamer motif correlates with the presence of Oct-4. Although a restriction of Oct-4 expression to the ICM is observed during blastocyst develop- ment, the question remains why the octamer motif is not active in trophoblast cells. The same reasons as outlined which lead to the lack of trans-activation of the 6W enhancer in HeLa cells might also account for the lack of activity in the trophoblast (see above). In addition, although Oct-4 transcripts are readily detectable in the trophoblast, it remains unclear whether they lead to an active translation product. It also remains unclear why Oct-4 is expressed in embryonic ectoderm and neural ectoderm. Prior to day 7, cells of the embryonic ectoderm have some degree of pluripotency and can give rise to many different cell types in teratocarcinomas (Evans and Kaufman, 1983) . Studies addressing the potency of embryonic ectoderm (Beddington, 1981 (Beddington, , 1982 Snow, 1981; Snow and Monk, 1983) indicate that distal ectoderm just posterior to the primitive streak from 7 day embryos can contribute to a variety of structures including somites, mesoderm, gut endoderm and notochord. Anterior ectoderm is more restricted in developmental potency and contributes primarily to head surface ectoderm and head neural ectoderm. The regional specification of the 7 day embryo is described in detail by Snow (1981) and Tam (1989) and appears to precede cell-type restriction, as there is little cell mixing along the anterior-posterior axis. The potency of ectodermal cells becomes more and more restricted beginning at approximately day 7. Although the three primary germ cell layers are all derived from the embryonic ectoderm, only the neural ectoderm still expresses Oct-4 at day 8. Thus, as cells of the ectoderm ingress through the primitive streak and form mesoderm, Oct-4 expression is shut off. Similarly, as the developmental potency of ectoderm cells in the neural plate becomes more restricted, Oct-4 expression is turned off. Only the primordial germ cells, also derived from ectoderm (Snow, 1981; Tam, 1989) , continue to express Oct-4; their developmental potency is unlimited, once differentiated and fertilized. In summary, Oct4 may be required to maintain potency in the cells of the early embryo.
Oct-4 maps in or near the major histocompatibility complex The chromosomal location of the Oct-4 gene was determined by recombinant inbred strain analysis (Taylor, 1978) . The same strain distribution pattern for Oct-4, Tla and H2-S was found, indicating that Oct-4 maps on chromosome 17 in or near the MHC complex (Lyon and Searle, 1989) . The MHC complex is located at the distal region of the t-complex, for which several dominant and recessive mutations are known (for a review see Frischauf, 1985 Several of the t-haplotype lethal alleles mapping to the MHC complex have profound effects on early mouse development. One complementation group is characterized by the failure of blastocyst formation on day 3 of development (tJ2 and tW32), a second shows defects in the formation of embryonic ectoderm (to and t6) and a third leads to death of embryonic ectoderm (tw5) (Magnuson, 1983 and ref. therein) . t°and t6 belong to a cluster of t-lethal alleles mapping close to tufted (tf) and therefore are too far away to be due to a mutation of the Oct-4 locus. However, the other two groups belong to a cluster of t-lethal alleles associated with the MHC locus (Artzt, 1984; Shin et al., 1984) .
Because Oct-4 is expressed during preimplantation development, t-lethal mutant phenotypes, which fail to form Fig. 9 . Sequence of the 6Wtk promoter region. Construction of p6WtkCAT as described by Scholer et al. (1989b) . The octamer motif, the TATA, GC and CAAT boxes are indicated above the sequence.
blastocysts, may be the result of a mutation or a deletion in the Oct-4 gene. t12 and t32 result in preimplantation lethality when homozygous. t12 homozygous embryos arrest in development at the late morula stage ( -32 cells ) (Smith, 1956 ) whereas those homozygous for tw32 arrest in development at the early morula stage (-16 cells) (Hillman et al., 1970) . t12/tw32 heterozygotes also die at the early morula stage (Hillman, 1975) .
The death of the embryonic ectoderm of tw5 homozygotes at day 7-8 correlates with the high levels of Oct-4 expression at this time. Some tw5 embryos develop to 10 days although they become completely extraembryonic and consist of only yolk sac, chorion and allantois (Bennett and Dunn, 1958) .
itub' (Winking and Guenet, 1978) is another allele belonging to the cluster of t-lethals associated with the MHC (Artzt, 1984) . However, extracts from an embryonal stem cell line homozygous for &lUlJ gave a strong Oct-4 complex in EMSA, indicating that synthesis of Oct-4 occurs and binding is not affected (data not shown). Oct4 is present in primordial germ cells, unfertilized oocytes and in the mouse blastocyst. Therefore this transcription factor could be regulating very early developmental processes, acting prior to other putative control genes, such as Hox or Pax genes. It will be interesting to determine whether Oct-4 regulates members of other gene families (Dressler and Gruss, 1988) . The dramatic down-regulation of Oct-4 expression after day 8 might be necessary for the differentiation of the embryonic ectoderm into different tissues. Although we have demonstrated that Oct-4 can act as a transcription factor, it might also repress transcription when the octamer motif is in a different context (Lenardo et al., 1989) . A more detailed mapping of the Oct-4 gene in relation to any of the t-mutants might allow a functional analysis.
Taken together, we think that Oct-4 is a good candidate for a gene involved in control events of early mouse development.
Materials and methods

Cell lines and transfection
HeLa cells were grown and transfected as described elsewhere (Scholer and Gruss, 1984; Scholer et al., 1989b) . HeLa cells were transfected with 15 yg reporter plasmid, 5 Ag expression vectors and 5 jig (3-actin-LacZ.
After harvesting, one-tenth of the cells were used for the microextraction procedure.
Recombinant plasmids and oligonucleotides ptkCAT, p6WtkCAT, p6FdtkCAT and the Oct-4 cDNA clone have been described previously (Scholer et al., 1989b and . The sequence of the 6Wtk promoter is shown in Figure 9 . CMV-Oct2A(+) has been described by Muller-Immergluck et al. (1988) . The Oct-2A cDNA in CMV-Oct2A(+) was replaced by Oct-4 cDNA (Figure la ; fragment A) in either sense or anti-sense orientation by standard recombinant procedures. Both SnaI restriction sites of CMV-Oct2A(+) were used for the replacement (E.Schreiber, personal communication). pD(3CAT and pdi3CAT were constructed by replacing the XbaI-XhoI fragment of ptkCAT (including the tk promoter) with the synthetic oligonucleotides indicated in Figure Id. (3-actin-lacZ is a plasmid containing the lacZ gene driven by the human (3-actin promoter (A.Puschel, unpublished data). The 1W oligonucleotide has been described previously (Scholer et al., 1989a) .
CAT and ,8-galactosidase assays CAT assays were performed as described elsewhere (Scholer and Gruss, 1984) with the following modifications: 150 td of a total of 180 Il were incubated for 3 h and 4 mM acetyl-CoA was added after 60 and 120 min. Autoradiography was performed for 72 h. (-galactosidase assays were performed as described in Sambrook et al. (1989) .
Isolation of blastocysts and day 7.5 -9.5 p.c. embryos Day 3.5 (blastocysts), 7.5, 8.5 and 9.5 embryos were isolated as described by Hogan et al. (1986) . Decidual tissue (day 7.5) and visceral yolk sac (day 8.5 and 9.5) were discarded and the embryos frozen immediately in liquid nitrogen.
Microextraction procedure for the preparation of whole cell extracts and the electrophoretic mobility shift assay (EMSA) The microextraction procedure and the EMSA were performed as described previously (Scholer et al., 1989a) except for using 100 mM NaCl in the extraction buffer.
DNA isolation and analysis Total cellular DNA from C57BL/6J and DBA/2J mice was isolated by standard techniques. B x D RI strain DNA was purchased from the Jackson Laboratory (Bar Harbor, Maine). Genomic DNA was digested, separated by electrophoresis and blotted onto GeneScreen Plus membrane by alkaline transfer. The filters were baked at 80'C for 30 min and hybridized overnight at 42°C in 50% formamide, 1 % SDS, 1 M NaCl with the Oct-4 probe (Figure la; fragment B) . The filters were washed twice at room temperature for 30 min in 2 x SSC, twice at 65°C for 30 min in 2 x SSC, 1 % SDS and finally twice in 0.1 x SSC at 650C for 30 min.
In situ hybridization (Figures 4, 5, 6 ) The techniques employed for in situ hybridization were essentially those of Hogan et al. (1986) with modifications by Dony and Gruss (1987) . Day 6, 7, 8 and 9 embryos were dissected out of the uterus but left in the decidua for sectioning. Day 11 embryos were dissected free of extra-embryonic tissues prior to sectioning. 8 ltm sections were cut at -200C, dried for 10-15 min at 55'C and fixed in 4% paraformaldehyde. Sections were pretreated in 2 x SSC at 70°C for 30 min and digested with 0.1 mg/ml pronase for 10 min at room temperature. After rinsing in PBS, sections were refixed in paraformaldehyde and dehydrated in graded ethanol. GGATCOGG=)OGCCCAGOGTCrTGTr,ATrGGCGAATrOGAACACW"TGCAGTCGGGGOG AGGTCCACTrOOCATATTM A 462 bp Oct-4 cDNA fragment (fragment C in Figure la) was cloned into Bluescript (Stratagene) and linearized with an appropriate restriction endonuclease. The highest homology of this probe to a known DNA sequence is < 70% (tst-1; N.Suzuki and H.R. Scholer, unpublished results) . RNA probes were transcribed using T3 and T7 polymerases according to the manufacturer's instructions (Promega). Labelled RNAs were precipitated with 10% TCA and collected on nitrocellulose filters. Probes were eluted from the filters in 50 mM EDTA, 0.1% SDS at 65°C for 30 min and subjected to limited alkaline hydrolysis to achieve an optimum probe length of 100-200 nucleotides. Probes were diluted to 5 x 104 c.p.m./Al in hybridization buffer containing 50% formamide, 10% dextran sulphate, 0.3 M NaCl, 10 mM Tris, 10 mM NaPO4 pH 6.8, 5 mM EDTA, 10 mM DTT, 1 x Denhardt's, and 10 AM [35S] ATP. Approximately 6-10 iLl of hybridization mix was used per section, depending on the size of the coverslip. Hybridization was performed overnight at 420C in a humid chamber. Slides were washed at 500C in 2 x SSC, 50% formamide at 370C until coverslips floated free. Slides were digested with 20 ig/mli of pancreatic RNase (Ingham et al., 1985) and washed overnight at 37°C in 50% formamide, 2 x SSC. Slides were dipped in Kodak NTB2 emulsion and exposed for 7 days. Slides were developed and stained with thionin.
Alkaline phosphatase activity was detected ujsing the method of Stinnakre et al. (1981) . The sections were fixed as for in situ hybridization and dehydrated. Sections were incubated for 10 min in 75 mM Tris pH 8.6, 0.8% NaCI, 2% dimethylformamide, 0.05% sodium napthol ASMX phosphate and 0.1 % fast red TR. Sections were rinsed in water briefly and counterstained for 1 min in neutral red.
In situ hybridization (Figure 3) The techniques employed for in situ hybridization of blastocysts were those of Hogan et al. (1989) and Graham et al. (1989) . Blastocysts were recovered from the oviduct and uterus (Hogan et al., 1989) and transferred into oviducts. Subsequently, the oviduct was dissected, fixed in 4% paraformaldehyde for 16 h at 4°C and embedded in paraffin wax. 6 Am sections were cut and dried for 60 min at 37°C. The sections were dewaxed in xylene, refixed in 4% paraformaldehyde, digested with 0.02 mg/mi proteinase K and treated with acetic anhydride. After dehydration the sections were hybridized with the probe (see above) for 16 h at 500C in a hybridization buffer containing 50% formamide, 10% dextran sulphate, 100 mM DTT, 0.3 M NaCI, 110 mM Tris, 5 mM EDTA, 10 mM sodium phosphate, 2% BSA, 2% polyvinylpyrrolidone, 2% Ficoll type 400. Slides were washed at 370C in 2% SSC, 50% formamide, 1 mM DTT for 4 h and subsequently treated with 20 Atg/ml RNase A at 370C for 15 min. Washing was continued for 16 h at 370C in 2% SSC, 50% formamide, 1 mM DTT, then slides were dehydrated and air dried. Slides were dipped in Kodak NTB2 emulsion, exposed for 10 days, developed and stained with Giemsa.
